ReviewFrontiers in immunology2021

Beyond First-Line Immune Checkpoint Inhibitor Therapy in Patients With Hepatocellular Carcinoma.

Rohini Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.